{"id":7216,"date":"2019-06-27T17:44:38","date_gmt":"2019-06-28T00:44:38","guid":{"rendered":"https:\/\/www.bluerocktx.com\/?p=7216"},"modified":"2023-06-26T14:11:55","modified_gmt":"2023-06-26T18:11:55","slug":"genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy","status":"publish","type":"post","link":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/","title":{"rendered":"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy"},"content":{"rendered":"<p>Moyes et al. validate approaches to engineer adult macrophages for payload delivery, establishing a platform with widespread utility. This is an effective proof point for functional derivation of similar macrophages derived from pluripotent stem cell sources. <a href=\"https:\/\/www.liebertpub.com\/doi\/abs\/10.1089\/hum.2016.060\" target=\"_blank\" rel=\"noopener\">Read more<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Moyes et al. validate approaches to engineer adult macrophages for payload delivery, establishing a platform with widespread utility. This is an effective proof point for functional derivation of similar macrophages derived from pluripotent stem cell sources. Read more.<\/p>\n","protected":false},"author":2,"featured_media":7714,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[50],"tags":[43],"class_list":["post-7216","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-insights","tag-immunology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy - BlueRock Therapeutics LP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy - BlueRock Therapeutics LP\" \/>\n<meta property=\"og:description\" content=\"Moyes et al. validate approaches to engineer adult macrophages for payload delivery, establishing a platform with widespread utility. This is an effective proof point for functional derivation of similar macrophages derived from pluripotent stem cell sources. Read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"BlueRock Therapeutics LP\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-28T00:44:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-26T18:11:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"225\" \/>\n\t<meta property=\"og:image:height\" content=\"225\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BlueRock Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BlueRock Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/\",\"url\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/\",\"name\":\"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy - BlueRock Therapeutics LP\",\"isPartOf\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg\",\"datePublished\":\"2019-06-28T00:44:38+00:00\",\"dateModified\":\"2023-06-26T18:11:55+00:00\",\"author\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#primaryimage\",\"url\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg\",\"contentUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg\",\"width\":225,\"height\":225,\"caption\":\"Mary Ann Liebert, Inc. logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.bluerocktx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.bluerocktx.com\/#website\",\"url\":\"https:\/\/www.bluerocktx.com\/\",\"name\":\"BlueRock Therapeutics LP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.bluerocktx.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\",\"name\":\"BlueRock Therapeutics\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"caption\":\"BlueRock Therapeutics\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy - BlueRock Therapeutics LP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/","og_locale":"en_US","og_type":"article","og_title":"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy - BlueRock Therapeutics LP","og_description":"Moyes et al. validate approaches to engineer adult macrophages for payload delivery, establishing a platform with widespread utility. This is an effective proof point for functional derivation of similar macrophages derived from pluripotent stem cell sources. Read more.","og_url":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/","og_site_name":"BlueRock Therapeutics LP","article_published_time":"2019-06-28T00:44:38+00:00","article_modified_time":"2023-06-26T18:11:55+00:00","og_image":[{"width":225,"height":225,"url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg","type":"image\/jpeg"}],"author":"BlueRock Therapeutics","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BlueRock Therapeutics","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/","url":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/","name":"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy - BlueRock Therapeutics LP","isPartOf":{"@id":"https:\/\/www.bluerocktx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#primaryimage"},"image":{"@id":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg","datePublished":"2019-06-28T00:44:38+00:00","dateModified":"2023-06-26T18:11:55+00:00","author":{"@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057"},"breadcrumb":{"@id":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#primaryimage","url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg","contentUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/download.jpeg","width":225,"height":225,"caption":"Mary Ann Liebert, Inc. logo"},{"@type":"BreadcrumbList","@id":"https:\/\/www.bluerocktx.com\/genetically-engineered-macrophages-a-potential-platform-for-cancer-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bluerocktx.com\/"},{"@type":"ListItem","position":2,"name":"Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.bluerocktx.com\/#website","url":"https:\/\/www.bluerocktx.com\/","name":"BlueRock Therapeutics LP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bluerocktx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057","name":"BlueRock Therapeutics","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","caption":"BlueRock Therapeutics"}}]}},"_links":{"self":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/7216"}],"collection":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/comments?post=7216"}],"version-history":[{"count":2,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/7216\/revisions"}],"predecessor-version":[{"id":7555,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/7216\/revisions\/7555"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media\/7714"}],"wp:attachment":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media?parent=7216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/categories?post=7216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/tags?post=7216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}